The Treatment of Interstitial Lung Disease Associated With Rheumatoid Arthritis With Inflixima

Dellaripa, Paul F.; Fry, Thomas A.; Willoughby, Janet; Arndt, William F.; Angelakis, Elizabeth J.; Campagna, Anthony C.

doi:10.1378/chest.124.4_meetingabstracts.109s-a

Cited by 9 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, Burke et al report that although opioids‐dependent individuals reported significant sleep disturbance, such sleep disturbance did not appear to affect daily functioning as assessed by the FOSQ (45). The FOSQ has been applied to a limited extent in populations with rheumatologic disease (49, 50). The FOSQ is frequently used as a measure of sleep‐specific health‐related quality of life.…”

Section: Functional Outcomes Of Sleep Questionnaire (Fosq)mentioning

confidence: 99%

Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI)

Omachi¹

2011

Arthritis Care & Research

101

View full text Add to dashboard Cite

Section: Functional Outcomes Of Sleep Questionnaire (Fosq)mentioning

confidence: 99%

Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI)

Omachi¹

2011

Arthritis Care & Research

101

View full text Add to dashboard Cite

“…8 In addition, infliximab tested in six patients with RA-associated interstitial lung disease induced stabilisation of the pulmonary disease in most cases. 9,10 In conclusion, we report a beneficial effect of TNF-a blockade in a patient with biopsy proven RAassociated bronchiolitis, a condition hitherto not amenable to improvement.…”

Section: Discussionmentioning

confidence: 64%

Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept

Cortot¹,

Cottin²,

Miossec³

et al. 2005

Respiratory Medicine

View full text Add to dashboard Cite

Rheumatoid arthritis (RA)-associated constrictive bronchiolitis is a severe condition with no established efficient treatment. A 55-year-old woman with seropositive RA developed rapidly progressive constrictive bronchiolitis confirmed by lung biopsy. Her clinical condition worsened despite steroids and azathioprine. Treatment with etanercept-a tumor necrosis factor (TNF)-alpha inhibitor-combined with methotrexate, resulted in a marked improvement of both her clinical condition and pulmonary function tests. Treatment with TNF-alpha inhibitors and methotrexate may be proposed in RA-associated constrictive bronchiolitis, a severe condition hitherto not amenable to improvement.

show abstract

“…Also, it was reported that when rituximab (1,000 mg at day 1, 15, and again at weeks 24 and 26, with methotrexate) was used concomitantly with methotrexate, FVC was maintained in six out of seven RA-ILD patients after 48 weeks102. Also, some case studies reported that azathioprine105, abatacept106, tocilizumab107, and infliximab108 each stabilized pulmonary function in RA-ILD patients.…”

Section: Treatment Of Ctd-ildmentioning

confidence: 99%

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease

et al. 2019

View full text Add to dashboard Cite

Connective tissue disease (CTD) is a collection of disorders characterized by various signs and symptoms such as circulation of autoantibodies in the entire system causing damage to internal organs. Interstitial lung disease (ILD) which is associated with CTD is referred to as CTD-ILD. Patients diagnosed with ILD should be thoroughly examined for the co-occurrence of CTD, since the treatment procedures and prognosis of CTD-ILD are vary from those of idiopathic interstitial pneumonia. The representative types of CTD which may accompany ILD include rheumatoid arthritis, systemic sclerosis (SSc), Sjögren's syndrome, mixed CTD, idiopathic inflammatory myopathies, and systemic lupus erythematous. Of these, ILD most frequently co-exists with SSc. If an ILD is observed in the chest, high resolution computed tomography and specific diagnostic criteria for any type of CTD are met, then a diagnosis of CTD-ILD is made. It is challenging to conduct a properly designed randomized study on CTD-ILD, due to low incidence. Therefore, CTD-ILD treatment approach is yet to been established in absence of randomized controlled clinical trials, with the exception of SSc-ILD. When a patient is presented with acute CTD-ILD or if symptoms occur due to progression of the disease, steroid and immunosuppressive therapy are generally considered.

show abstract

The Treatment of Interstitial Lung Disease Associated With Rheumatoid Arthritis With Inflixima

Cited by 9 publications

References 0 publications

Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI)

Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI)

Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease

Contact Info

Product

Resources

About